Other News To Note

Cynapsus Therapeutics Inc., of Toronto, said it plans to proceed with its all-stock acquisition of Hamilton, Ontario-based Adagio Pharmaceuticals Ltd., its partner on APL-130277, a reformulation of an approved Parkinson's drug.